Clinical outcomes of early-stage breast cancer in Morocco: A cohort of 400 women

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Nov 24, 2025; 16(11): 110687
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.110687

Table 2 Treatments used in women with early-stage breast cancer in Morocco (n = 400)

Treatment	Patients (n)	%
Surgery
Mastectomy	344	86.0
Breast-conserving surgery	56	14.0
Chemotherapy
Anthracycline-based regimen	249	62.2
CMF regimen	151	37.8
Radiotherapy - breast/thoracic wall
Breast	56	14.0
Thoracic wall	344	86.0
Radiotherapy - lymph nodes
Supraclavicular ± IMC	333	83.2
Axillary	60	15.0

BCT: Breast-conserving surgery; CMF: Cyclophosphamide, methotrexate, fluorouracil; IMC: Internal mammary chain.

Citation: Ismaili N, Guessous F, El Majjaoui S. Clinical outcomes of early-stage breast cancer in Morocco: A cohort of 400 women. World J Clin Oncol 2025; 16(11): 110687
URL: https://www.wjgnet.com/2218-4333/full/v16/i11/110687.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i11.110687

Ismaili N, Guessous F, El Majjaoui S. Clinical outcomes of early-stage breast cancer in Morocco: A cohort of 400 women. World J Clin Oncol 2025; 16(11): 110687 [PMID: 41355902 DOI: 10.5306/wjco.v16.i11.110687]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.